A Phase I Dose Escalation Study of RAD001 in Combination With Chemotherapy and Radiation in Patients With NSCLC.

Trial Profile

A Phase I Dose Escalation Study of RAD001 in Combination With Chemotherapy and Radiation in Patients With NSCLC.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 03 Jul 2012

At a glance

  • Drugs Cisplatin; Everolimus; Pemetrexed
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Jul 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 03 Jul 2012 Actual patient number is 3 according to ClinicalTrials.gov.
    • 03 Jul 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top